文献速递淋巴瘤

伯基特淋巴瘤的肿瘤微环境:不同免疫特征对应不同临床行为

Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior.
PubMed 文献 · Blood Adv · 2024-01-01

研究通过NanoString nCounter平台对7例伴肉芽肿反应的EBV阳性伯基特淋巴瘤、8例典型满天星图案的EBV阳性伯基特淋巴瘤及8例EBV阴性伯基特淋巴瘤进行基因表达谱分析,并用多重及联合免疫染色验证。结果显示三组样本形成三个不同聚类,伴弥漫性肉芽肿反应的伯基特淋巴瘤呈促炎反应特征,而满天星图案者表现为M2极化和促肿瘤反应上调。

要点

  • 伴弥漫性肉芽肿反应的伯基特淋巴瘤肿瘤微环境呈促炎反应特征。
  • 典型满天星图案的伯基特淋巴瘤表现为M2极化和促肿瘤反应上调。
  • 肿瘤相关巨噬细胞和表观遗传调控因子可能是伯基特淋巴瘤的潜在治疗靶点。

核心结论

  • 伴肉芽肿反应的伯基特淋巴瘤与典型满天星图案者在免疫反应特征上存在差异,肿瘤相关巨噬细胞和表观遗传调控因子可能是伯基特淋巴瘤额外治疗的 promising 靶点,为新的免疫治疗策略开辟道路。

研究设计与样本

  • 研究对7例伴肉芽肿反应的EBV阳性伯基特淋巴瘤、8例典型满天星图案的EBV阳性伯基特淋巴瘤和8例EBV阴性伯基特淋巴瘤,在NanoString nCounter平台上进行基因表达谱分析,随后用多重和联合免疫染色验证。

主要发现

  • 基于差异表达基因的无监督聚类,伯基特淋巴瘤样本形成3个不同聚类:聚类1富集伴弥漫性肉芽肿反应的伯基特淋巴瘤,聚类2富集典型满天星图案的EBV阳性伯基特淋巴瘤,聚类3富集典型满天星图案的EBV阴性伯基特淋巴瘤。
  • 伴弥漫性肉芽肿反应的伯基特淋巴瘤肿瘤微环境特征显示促炎反应,而满天星图案的伯基特淋巴瘤以M2极化和促肿瘤反应上调为特征。
  • 额外特征分析显示,典型满天星图案的伯基特淋巴瘤中暗区特征和表观遗传特征上调。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Burkitt lymphoma (BL) is characterized by a tumor microenvironment (TME) in which macrophages represent the main component, determining a distinct histological appearance known as "starry sky" pattern. However, in some instances, BL may exhibit a granulomatous reaction that has been previously linked to favorable prognosis and spontaneous regression. The aim of our study was to deeply characterize the immune landscape of 7 cases of Epstein-Barr virus-positive (EBV+) BL with granulomatous reaction compared with 8 cases of EBV+ BL and 8 EBV-negative (EBV-) BL, both with typical starry sky pattern, by Gene expression profiling performed on the NanoString nCounter platform. Subsequently, the data were validated using multiplex and combined immunostaining. Based on unsupervised clustering of differentially expressed genes, BL samples formed 3 distinct clusters differentially enriched in BL with a diffuse granulomatous reaction (cluster 1), EBV+ BL with typical starry sky pattern (cluster 2), EBV- BL with typical "starry sky" (cluster 3). We observed variations in the immune response signature among BL with granulomatous reaction and BL with typical "starry sky," both EBV+ and EBV-. The TME signature in BL with diffuse granulomatous reaction showed a proinflammatory response, whereas BLs with "starry sky" were characterized by upregulation of M2 polarization and protumor response. Moreover, the analysis of additional signatures revealed an upregulation of the dark zone signature and epigenetic signature in BL with a typical starry sky. Tumor-associated macrophages and epigenetic regulators may be promising targets for additional therapies for BL lymphoma, opening novel immunotherapeutic strategies.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Siciliano MC, Bertolazzi G, Morello G, et al. Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior. Blood Adv. 2024. PMID: 38861355. doi:10.1182/bloodadvances.2023011506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。